Copyright © 2019 EnBiotix, Inc.. All Rights Reserved
Viewing posts categorised under: Uncategorized

BioWorld: EnBiotix Inc.: Antibiotic Helpers for Resistant, Persistent Bugs

Posted by enbiotixadmin in Uncategorized | 0 comments


It may be a bad environment for early stage deals for most companies. But not for start-up EnBiotix Inc., according to its CEO Jeffrey Wager.  The company, which was founded in 2012, is “in discussions with multiple pharma companies” for partnering opportunities.  The reason, Wager told BioWorld Today, lies in the company’s approach. EnBiotix is not trying to develop standalone antibiotics. Instead, its technologies “could be potentiating a significant proportion of the antibiotics that are currently out there.” Full Article

Nature Biotechnology: Startups on the Menu: EnBiotix

Posted by enbiotixadmin in Uncategorized | 0 comments


Boston University’s (BU) Jim Collins presented work from his lab on a network biology approach to antibiotic discovery at the Boston SciCafé, Nature Biotechnology‘s and Nature Medicine‘s tri-annual gathering of academic researchers and business people. He’s now a cofounder of EnBiotix, a startup focused around this technology, to develop new classes of antibiotics and antibiotic potentiators to tackle multidrug-resistant microbes. Nature Biotechnology talked to him about the company. Full Article